Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersions

References

• Saharan VA, Kukkar V, Kataria M, Gera M, Choudhury PK. (2009). Dissolution enhancement of drugs. Part I: technologies and effect of carriers. Int J Health Res, 2:107–124.
   Google Scholar
• Lordi NG. (1986). Sustained release dosage form. In: The Theory and Practice of Industrial Pharmacy. 3rd edition. Philadelphia, USA: Lea Febiger, 430–456.
   Google Scholar
• Miller-Chou BA, Koenig JL. (2003). A review of polymer dissolution. Prog Polym Sci, 28:1223–1270.
   Web of Science ®Google Scholar
• Esnaashari S, Javadzadeh Y, Batchelor HK, Conway BR. (2005). The use of microviscometry to study polymer dissolution from solid dispersion drug delivery systems. Int J Pharm, 292:227–230.
   PubMed Web of Science ®Google Scholar
• Khan S, Batchelor H, Hanson P, Perrie Y, Mohammed AR. (2011). Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000. J Pharm Sci, 100:4281–4294.
   PubMed Web of Science ®Google Scholar
• Craig DQ. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm, 231:131–144.
   PubMed Web of Science ®Google Scholar
• Chiou WL, Riegelman S. (1971). Pharmaceutical applications of solid dispersion systems. J Pharm Sci, 60:1281–1302.
   PubMed Web of Science ®Google Scholar
• Shah VP, Tsong Y, Sathe P, Liu JP. (1998). In vitro dissolution profile comparison–statistics and analysis of the similarity factor, f2. Pharm Res, 15:889–896.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Buri P, Doelker E, Gurney R, Peppas NA. (1983). Mechanism of release from porous hydrophilic polymers. Int J Pharm, 15:25–35.
   Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• Artursson P, Palm K, Luthman K. (1996). Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev, 22:67–84.
   Web of Science ®Google Scholar
• Artursson P, Borchardt RT. (1997). Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm Res, 14:1655–1658.
   PubMed Web of Science ®Google Scholar
• Guidance for Industry. (2000). Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification system. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER).
   Google Scholar
• Rubas W, Cromwell ME, Shahrokh Z, Villagran J, Nguyen TN, Wellton M et al. (1996). Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. J Pharm Sci, 85:165–169.
   PubMed Web of Science ®Google Scholar
• Sweetman SC. (2002). 33rd edition. Martindale. The Complete Drug Reference. London: Pharm Press.
   Google Scholar
• Kramer WG, Rensimer ER, Ericsson CD, Pickering LK. (1984). Comparative bioavailability of intravenous and oral chloramphenicol in adults. J Clin Pharmacol, 24:181–186.
   PubMed Web of Science ®Google Scholar
• World Health Organization, WHO. (2006). Technical Report Series, No. 937:391–437.
   Google Scholar
• Dubois JL, Ford JL. (1985). Similarities in the release rates of different drugs from polyethylene glycol 6000 solid dispersions. J Pharm Pharmacol, 37:494–495.
   PubMed Web of Science ®Google Scholar
• Akay C, Ozkan SA. (2002). Simultaneous LC determination of trimethoprim and sulphamethoxazole in pharmaceutical formulations. J Pharm Biomed Anal, 30:1207–1213.
   PubMed Web of Science ®Google Scholar
• Hong L, Altorfer H. (2001). Determination of assay and impurities of gamma irradiated chloramphenicol in eye ointment. J Pharm Biomed Anal, 24:667–674.
   PubMed Web of Science ®Google Scholar
• Khan S, Elshaer A, Rahman AS, Hanson P, Perrie Y, Mohammed AR. (2011). Systems biology approach to study permeability of paracetamol and its solid dispersion. Int J Pharm, 417:272–279.
   PubMed Web of Science ®Google Scholar
• Khan S, Elshaer A, Rahman AS, Hanson P, Perrie Y, Mohammed AR. (2011). Genomic evaluation during permeability of indomethacin and its solid dispersion. J Drug Target, 19:615–623.
   PubMed Web of Science ®Google Scholar
• Yin L, Huang S, Zhu C, Zhang S, Zhang Q, Chen X, Liu Q. (2012). In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier. Drug Dev Ind Pharm (Posted online on 2 Feb 2012).
   Google Scholar
• Ahuja N, Katare OP, Singh B. (2007). Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm, 65:26–38.
   PubMed Web of Science ®Google Scholar
• Dordunoo SK, Ford JL, Rubinstein MH. (1991). Preformulation studies on solid dispersions containing triamterene or temazepam in polyethylene glycols or Gelucire 44/14 for liquid filling of hard gelatin capsules. Drug Dev Ind Pharm, 17:685–1713.
   Google Scholar
• Frances C, Veiga MD, Espafiol OM, Cadorniga R. (1991). Preparation, characterisation and dissolution of ciprofloxacin/PEG 6000 binary systems. Int J Pharm, 77:193–198.
   Web of Science ®Google Scholar
• Aggarwal AK, Singh S. (2011). Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000. Drug Dev Ind Pharm, 37:1181–1191.
   PubMed Web of Science ®Google Scholar
• Al-Angary AA, A1-Meshal MA, Bayomi MA, Khidr, SH. (1996). Evaluation of liposomal formulations containing the antimalarial agent, arteether. Int J Pharm, 128:163–168.
   Web of Science ®Google Scholar
• Palanisamy M, Khanam J. (2011). Solid dispersion of prednisolone: solid state characterization and improvement of dissolution profile. Drug Dev Ind Pharm, 37:373–386.
   PubMed Web of Science ®Google Scholar
• Teresa MM, Victoria MM, Salcedo GE. (2002). Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone. Il. Farmaco, 57:723–727.
   PubMedGoogle Scholar
• Jachowicz R, Nurnberg E, Hoppe R. (1993). Solid dispersions of oxazepam. Int J Pharm, 99:321–325.
   Web of Science ®Google Scholar
• Margarit MV, Rodriguez IC, Cerezo A. (1994). Physical characteristics and dissolution kinetics of solid dispersions of ketoprofen and polyethylene glycol 6000. Int J Pharm, 108:101–107.
   Web of Science ®Google Scholar
• Suzuki H, Sunada H. (1997). Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems. Chem Pharm Bull, 45:1688–1693.
   PubMed Web of Science ®Google Scholar
• Feng J, Xu L, Gao R, Luo Y, Tang X. (2011). Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm, 1–9.
   Google Scholar
• Sekikawa H, Naganuma T, Fujiwara JE, Nakano M, Arita T. (1979). Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitate. Chem Pharm Bull, 27:1223–1230.
   PubMed Web of Science ®Google Scholar
• Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. (1999). Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm, 181:143–151.
   PubMed Web of Science ®Google Scholar
• Ford JL. (1986). The current status of solid dispersions. Pharm Acta Helv, 61:69–88.
   PubMedGoogle Scholar
• Simoneli AP, Mehtha SC, Higuchi WI. (1976). Dissolution rates of high energy sulphathiazole-povidone coprecipitates II. Characterization of the form of drug controlling its dissolution rate via solubility studies. J Pharm Sci, 65:355–361.
   PubMed Web of Science ®Google Scholar
• Betageri GV, Dipali SR. (1995). Preparation and in vitro dissolution profiles of tolazamide-polyethylene glycol solid dispersions. Drug Dev Ind Pharm, 21:1347–1352.
   Web of Science ®Google Scholar
• Karekar P, Vyas V, Shah M, Sancheti P, Pore Y. (2009). Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188. Pharm Dev Technol, 14:373–379.
   PubMed Web of Science ®Google Scholar
• Maniruzzaman M, Rana MM, Boateng JS, Mitchell JC, Douroumis D. (2012 March 23). Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers. Drug Dev Ind Pharm.
   PubMed Web of Science ®Google Scholar
• Silva TD, Arantes VT, Resende JA, Speziali NL, de Oliveira RB, Vianna-Soares CD. (2010). Preparation and characterization of solid dispersion of simvastatin. Drug Dev Ind Pharm, 36:1348–1355.
   PubMed Web of Science ®Google Scholar
• Yee S. (1997). In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man–fact or myth. Pharm Res, 14:763–766.
   PubMed Web of Science ®Google Scholar
• Johnson BM, Charman WN, Porter CJ. (2002). An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine. AAPS PharmSci, 4:E40.
   PubMedGoogle Scholar